TRAIL/TRAIL Receptor System and Susceptibility to Multiple Sclerosis

The genetics of multiple sclerosis: An update 2010

(2010) Sabine Hoffjan et al.   MOLECULAR AND CELLULAR PROBES

TRAIL receptor mediates inflammatory cytokine release in an NF-κB-dependent manner

(2009) Wanhu Tang et al.   CELL RESEARCH

Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses

(2009) Adam Collison et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Multiple sclerosis and the major histocompatibility complex

(2009) Sreeram V Ramagopalan et al.   CURRENT OPINION IN NEUROLOGY

Following TRAIL’s path in the immune system

(2009) Christina Falschlehner et al.   IMMUNOLOGY

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation

(2009) Olaf Hoffmann et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

(2008) Sergio E. Baranzini et al.   HUMAN MOLECULAR GENETICS

Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis

(2008) Yurii S Aulchenko et al.   NATURE GENETICS

The genetics of multiple sclerosis: SNPs to pathways to pathogenesis

(2008) Jorge R. Oksenberg et al.   NATURE REVIEWS GENETICS